Matthew Widner1, Mark Dunleavy2, Scott Lynch2. 1. Department of Orthopaedics and Rehabilitation, Pennsylvania State University College of Medicine, 30 Hope Drive, Hershey, PA, 17033, USA. mwidner@pennstatehealth.psu.edu. 2. Department of Orthopaedics and Rehabilitation, Pennsylvania State University College of Medicine, 30 Hope Drive, Hershey, PA, 17033, USA.
Abstract
PURPOSE OF REVIEW: Anterior cruciate ligament reconstruction is one of the most common orthopedic procedures performed, accounting for over 200,000 cases annually. Despite the high prevalence, there is still much debate as to the optimal graft choice. The purpose of this review is to evaluate the current literature and discuss the reported outcomes for the most common graft choices. RECENT FINDINGS: The most common autografts being used include bone-patellar tendon-bone (BPTB), hamstring tendon (HT), and quadriceps tendon (QT). Hamstring tendon might have a slightly higher re-tear rate when compared with BPTB (2.84 versus 2.80). However, BPTB has a higher rate of anterior knee and kneeling pain in the short- and mid-term follow-up. This has not been shown to be the case in long-term follow-up. Allograft is a viable option for revisions and primaries in patients greater than 35 years old; however, re-tear rate increases significantly in younger patients. ACL reconstruction graft choice is a highly studied and yet still exceedingly debated topic. Most large studies report either no significant difference or a small difference in failure rate and outcome scores between the different autograft choices. Allografts have been demonstrated to have an increased risk of failure in younger athletes and should be reserved for revision cases and those aged 35 years and older. Graft choice should ultimately be decided upon based on surgeon comfort and experience and individual patient characteristics.
PURPOSE OF REVIEW: Anterior cruciate ligament reconstruction is one of the most common orthopedic procedures performed, accounting for over 200,000 cases annually. Despite the high prevalence, there is still much debate as to the optimal graft choice. The purpose of this review is to evaluate the current literature and discuss the reported outcomes for the most common graft choices. RECENT FINDINGS: The most common autografts being used include bone-patellar tendon-bone (BPTB), hamstring tendon (HT), and quadriceps tendon (QT). Hamstring tendon might have a slightly higher re-tear rate when compared with BPTB (2.84 versus 2.80). However, BPTB has a higher rate of anterior knee and kneeling pain in the short- and mid-term follow-up. This has not been shown to be the case in long-term follow-up. Allograft is a viable option for revisions and primaries in patients greater than 35 years old; however, re-tear rate increases significantly in younger patients. ACL reconstruction graft choice is a highly studied and yet still exceedingly debated topic. Most large studies report either no significant difference or a small difference in failure rate and outcome scores between the different autograft choices. Allografts have been demonstrated to have an increased risk of failure in younger athletes and should be reserved for revision cases and those aged 35 years and older. Graft choice should ultimately be decided upon based on surgeon comfort and experience and individual patient characteristics.
Authors: Craig R Bottoni; Eric L Smith; James Shaha; Steven S Shaha; Sarah G Raybin; John M Tokish; Douglas J Rowles Journal: Am J Sports Med Date: 2015-08-26 Impact factor: 6.202
Authors: Eoghan T Hurley; Manuel Calvo-Gurry; Dan Withers; Shane K Farrington; Ray Moran; Cathal J Moran Journal: Arthroscopy Date: 2018-04-05 Impact factor: 4.772
Authors: Lisa Tibor; Priscilla H Chan; Tadashi T Funahashi; Ronald Wyatt; Gregory B Maletis; Maria C S Inacio Journal: J Bone Joint Surg Am Date: 2016-07-06 Impact factor: 5.284
Authors: Thomas L Sanders; Ayoosh Pareek; Hilal Maradit Kremers; Andrew J Bryan; Bruce A Levy; Michael J Stuart; Diane L Dahm; Aaron J Krych Journal: Knee Surg Sports Traumatol Arthrosc Date: 2016-05-24 Impact factor: 4.342
Authors: V Condello; U Zdanowicz; Berardo Di Matteo; T Spalding; P E Gelber; P Adravanti; P Heuberer; S Dimmen; B Sonnery-Cottet; C Hulet; M Bonomo; E Kon Journal: Knee Surg Sports Traumatol Arthrosc Date: 2018-09-21 Impact factor: 4.342
Authors: Eric Hamrin Senorski; Eleonor Svantesson; Angelo Baldari; Olufemi R Ayeni; Lars Engebretsen; Francesco Franceschi; Jón Karlsson; Kristian Samuelsson Journal: Br J Sports Med Date: 2018-07-20 Impact factor: 13.800
Authors: Steven F DeFroda; Ryan M ODonnell; Paul D Fadale; Brett D Owens; Braden C Fleming Journal: Phys Sportsmed Date: 2020-09-30 Impact factor: 2.241
Authors: S Supreeth; S A Ghanami; M A Riyami; S A Habsi; P S Murthi; W A Kalbani; H A Saqri; S N Haddad; S R Abdelmasih Journal: Musculoskelet Surg Date: 2022-03-12